Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis

Autor: Stéphanie Petrella, Alexandra Aubry, Nicolas Veziris, Hélène Ferrand, Claudine Mayer, Aurélie Bouige, Alix Pantel, Stéphanie Matrat, Wladimir Sougakoff
Přispěvatelé: Université Pierre et Marie Curie - Paris 6 (UPMC), Microbiologie structurale - Structural Microbiology (Microb. Struc. (UMR_3528 / U-Pasteur_5)), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Centre d'Immunologie et de Maladies Infectieuses (CIMI), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Parts of this paper were presented at the ‘International Conference on Antimicrobial Agents and Chemotherapy’, USA, 2011 (C1-626), and at the EMBO Conference ‘Tuberculosis 2012’, France, 2012 (TUBERCULOSIS2012/000269)., Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène [CHU Pitié-Salpêtrière] ], CHU Pitié-Salpêtrière [APHP]
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
MESH: Mycobacterium tuberculosis
DNA Mutational Analysis
Mutant
Antitubercular Agents
medicine.disease_cause
DNA gyrase
MESH: Recombinant Proteins
Suppression
Genetic

[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Pharmacology (medical)
MESH: DNA Mutational Analysis
MESH: Suppression
Genetic

MESH: Inhibitory Concentration 50
Mutation
MESH: Microbial Sensitivity Tests
biology
Chemistry
MESH: Escherichia coli
Recombinant Proteins
3. Good health
MESH: Mutagenesis
Site-Directed

Infectious Diseases
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
DNA Gyrase
DNA supercoil
Fluoroquinolones
medicine.drug
MESH: DNA Gyrase
Microbiology (medical)
030106 microbiology
Mutation
Missense

Microbial Sensitivity Tests
Microbiology
Mycobacterium tuberculosis
Inhibitory Concentration 50
03 medical and health sciences
Drug Resistance
Bacterial

MESH: Drug Resistance
Bacterial

Escherichia coli
medicine
Humans
Pharmacology
MESH: Mutation
Missense

MESH: Humans
Mutagenesis
MESH: Fluoroquinolones
biology.organism_classification
MESH: Antitubercular Agents
Mutagenesis
Site-Directed

[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
Ofloxacin
Zdroj: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 2016, 71 (9), pp.2428-2431. ⟨10.1093/jac/dkw169⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2016, 71 (9), pp.2428-2431. ⟨10.1093/jac/dkw169⟩
ISSN: 0305-7453
1460-2091
DOI: 10.1093/jac/dkw169⟩
Popis: International audience; OBJECTIVES:Resistance to fluoroquinolones (FQs) in Mycobacterium tuberculosis (Mtb) is mainly due to mutations in DNA gyrase (GyrA2B2), with the most common substitutions located at positions 90 and 94 in GyrA. Two clinical MDR Mtb (MDR-TB) strains harbouring an A90E or D94N substitution in GyrA were found to be surprisingly susceptible to FQs (ofloxacin MIC ≤2 mg/L). We studied the impact of the additional GyrA substitutions found in these strains (T80A and T80A + A90G, respectively) on FQ susceptibility.METHODS:Mutants of interest were generated by site-specific mutagenesis of GyrA alleles. WT and mutant TB DNA gyrase subunits were overexpressed in Escherichia coli and purified, and the in vitro susceptibility to FQs of their DNA supercoiling reaction was studied.RESULTS:IC50s of mutant gyrase complexes bearing GyrA D94N and A90E were 3- to 36-fold higher than WT IC50s, whereas IC50s of gyrase bearing T80A + A90G + D94N and T80A + A90E were close to the WT IC50s.CONCLUSIONS:We demonstrated that substitutions T80A and A90G restore FQ susceptibility when associated with a substitution implicated in high-level FQ resistance. Line probe assay misclassification of MDR-TB strains as pre-XDR or XDR can be corrected by sequence analysis of gyrA.
Databáze: OpenAIRE